CI vs. DGX: Cigna vs. Quest Diagnostics Stock Comparison
How do Cigna (CI) and Quest Diagnostics (DGX) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Cigna (CI) and Quest Diagnostics (DGX) are both classified in the Health Care Services sub-industry within the broader Health Care Providers & Services industry, placing them in the closest GICS peer bucket.
| Profile Item | CI | DGX |
|---|---|---|
| Name | The Cigna Group | Quest Diagnostics Incorporated |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Services | Health Care Services |
| Market Capitalization | 77.36 billion USD | 28.21 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 31, 1982 | December 17, 1996 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | CI | DGX |
|---|---|---|
| Total Return (1Y) | 13.95% | 45.88% |
| Total Return (3Y, Annualized) | 2.65% | 27.45% |
| Total Return (5Y, Annualized) | 8.40% | 14.84% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | CI | DGX |
|---|---|---|
| Volatility (1Y, Annualized) | 26.82% | 24.06% |
| Beta (5Y) | 0.24 | 0.54 |
| Max Drawdown (5Y) | -32.10% | -28.62% |
| Avg. Volume (3M) | 1.55M | 1.00M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | CI | DGX |
|---|---|---|
| Sharpe Ratio (1Y) | 0.36 | 1.73 |
| Sortino Ratio (1Y) | 0.54 | 3.16 |
Profitability
ROE (TTM)
Both Cigna (CI) at 15.65% and Quest Diagnostics (DGX) at 15.32% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.
CI
Health Care Equipment & Services industry group
15.65%
- Max
- 47.61%
- CI
- 15.65%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
DGX
Health Care Equipment & Services industry group
15.32%
- Max
- 47.61%
- DGX
- 15.32%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Quest Diagnostics (DGX) at 9.54% retains a top-quartile share of revenue as profit, ahead of Cigna (CI) at 2.09%, which keeps about the industry-typical share.
CI
Health Care Equipment & Services industry group
2.09%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- CI
- 2.09%
- Q1
- -6.29%
- Min
- -28.46%
DGX
Health Care Equipment & Services industry group
9.54%
- Max
- 29.35%
- DGX
- 9.54%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Quest Diagnostics (DGX) at 15.63% operates in the top operating margin quartile, ahead of Cigna (CI) at 3.48%, which runs around its industry’s norm.
CI
Health Care Equipment & Services industry group
3.48%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- CI
- 3.48%
- Q1
- -0.28%
- Min
- -16.29%
DGX
Health Care Equipment & Services industry group
15.63%
- Max
- 35.43%
- DGX
- 15.63%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | CI | DGX |
|---|---|---|
| ROE (TTM) | 15.65% | 15.32% |
| ROA (TTM) | 4.29% | 6.61% |
| Net Margin (TTM) | 2.09% | 9.54% |
| Operating Margin (TTM) | 3.48% | 15.63% |
| Gross Margin (TTM) | 9.09% | 33.18% |
Growth
Revenue Growth
Both Cigna (CI) at 11.26% and Quest Diagnostics (DGX) at 11.78% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Cigna (CI) at 83.00% sits in the top EPS growth quartile, while Quest Diagnostics (DGX) at 13.78% is closer to the peer norm — faster per-share earnings growth for CI.
Growth Metrics
| Metric | CI | DGX |
|---|---|---|
| Revenue Growth (YoY) | 11.26% | 11.78% |
| Revenue Growth (3Y CAGR) | 15.15% | 3.74% |
| EPS Growth (YoY) | 83.00% | 13.78% |
| EPS Growth (3Y CAGR) | 1.36% | 3.16% |
Financial Strength
Current Ratio (MRQ)
Quest Diagnostics (DGX) at 1.70 keeps current ratio within its industry’s typical mid-range, while Cigna (CI) at 0.84 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for CI.
CI
Health Care Equipment & Services industry group
0.84
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- CI
- 0.84
- Min
- 0.30
DGX
Health Care Equipment & Services industry group
1.70
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DGX
- 1.70
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Cigna (CI) at 0.71 and Quest Diagnostics (DGX) at 0.80 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
CI
Health Care Equipment & Services industry group
0.71
- Max
- 1.88
- Q3
- 0.91
- CI
- 0.71
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
DGX
Health Care Equipment & Services industry group
0.80
- Max
- 1.88
- Q3
- 0.91
- DGX
- 0.80
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | CI | DGX |
|---|---|---|
| Current Ratio (MRQ) | 0.84 | 1.70 |
| Debt / Equity (MRQ) | 0.71 | 0.80 |
| Net Debt / EBITDA | 1.87 | 2.38 |
Dividends
Dividend Yield (TTM)
Both Cigna (CI) at 2.05% and Quest Diagnostics (DGX) at 1.33% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
CI
Health Care Equipment & Services industry group
2.05%
- CI
- 2.05%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DGX
Health Care Equipment & Services industry group
1.33%
- DGX
- 1.33%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both Cigna (CI) at 27.29% and Quest Diagnostics (DGX) at 25.10% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.
CI
Health Care Equipment & Services industry group
27.29%
- CI
- 27.29%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DGX
Health Care Equipment & Services industry group
25.10%
- DGX
- 25.10%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | CI | DGX |
|---|---|---|
| Dividend Yield (TTM) | 2.05% | 1.33% |
| Dividend Payout Ratio (TTM) | 27.29% | 25.10% |
Valuation
P/E Ratio (TTM)
Cigna (CI) at 12.94 sits in the cheaper P/E ratio quartile, while Quest Diagnostics (DGX) at 25.46 is closer to its industry’s usual earnings multiple — a discount for CI, though growth and earnings durability still matter.
CI
Health Care Equipment & Services industry group
12.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- CI
- 12.94
- Min
- 4.21
DGX
Health Care Equipment & Services industry group
25.46
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- DGX
- 25.46
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Cigna (CI) at 0.27 sits in the cheaper P/S ratio quartile while Quest Diagnostics (DGX) at 2.38 prices around its industry’s middle — CI costs less per dollar of sales, though read it alongside growth and margins.
CI
Health Care Equipment & Services industry group
0.27
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- CI
- 0.27
- Min
- 0.03
DGX
Health Care Equipment & Services industry group
2.38
- Max
- 8.80
- Q3
- 4.32
- DGX
- 2.38
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Cigna (CI) at 1.79 and Quest Diagnostics (DGX) at 3.68 are valued close to their industries’ norm against book — neither stands out from peers.
CI
Health Care Equipment & Services industry group
1.79
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- CI
- 1.79
- Q1
- 1.73
- Min
- -1.31
DGX
Health Care Equipment & Services industry group
3.68
- Max
- 11.68
- Q3
- 6.12
- DGX
- 3.68
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | CI | DGX |
|---|---|---|
| P/E Ratio (TTM) | 12.94 | 25.46 |
| P/S Ratio (TTM) | 0.27 | 2.38 |
| P/B Ratio (MRQ) | 1.79 | 3.68 |
| Free Cash Flow Yield (TTM) | 10.59% | 3.09% |